HBW
IART icon

Hazlett, Burt & Watson’s Integra LifeSciences IART Stock Holding History

Hazlett, Burt & Watson’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9K Hold
925
– – ﹤0.01% 708
2025
Q4 		$11K Hold
925
– – ﹤0.01% 692
2025
Q3 		$13K Buy
+925
New +$12.7K ﹤0.01% 623

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hazlett, Burt & Watson's IART Position: Q1 2026 in Review

Hazlett, Burt & Watson held its Integra LifeSciences (IART) position steady in Q1 2026 at 925 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #708.

Hazlett, Burt & Watson first reported a position in IART in Q3 2025 and has held it in 3 quarters since. The position peaked at $13K in Q3 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Hazlett, Burt & Watson held 925 shares of Integra LifeSciences worth $9K as of Q1 2026.
  • Hazlett, Burt & Watson left its Integra LifeSciences share count unchanged in Q1 2026.
  • Integra LifeSciences made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #708 holding.
  • Hazlett, Burt & Watson first reported a position in Integra LifeSciences in Q3 2025 and has held it in 3 quarters since.
  • Hazlett, Burt & Watson's Integra LifeSciences position peaked at $13K in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.